Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Open in API
Filings indexed 822 across all filing types
Latest filing 2015-11-10 Report Publication Anno…
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Report of Periodic or Interim Report
Report Publication Announcement Classification · 1% confidence The document is a short notification (1611 characters) from Kamada Ltd. submitted to the Israel Securities Authority. It explicitly states 'Attached hereto is a report on Q3 2015 Financial reports' and provides a filename for the attachment. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement. 9M 2015
2015-11-10 English
Immediate Report
Regulatory Filings
2015-11-10 Hebrew (modern)
Immediate Report
Earnings Release Classification · 1% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. The key sentence is: 'Attached hereto is a report on *Kamada Reports Third Quarter 2015 Financial Results*'. This indicates the document itself is an announcement *about* the release of the Third Quarter financial results, rather than the full financial report (which would be an IR or 10-Q/10-K). Since it announces the publication of periodical financial results, the most appropriate classification is 'Earnings Release' (ER). The document length is short (1608 chars), supporting the 'Menu vs Meal' rule, suggesting it's an announcement (RPA/ER) rather than the full report. Q3 2015
2015-11-10 English
Other Report or Announcement
Regulatory Filings
2015-11-10 Hebrew (modern)
Other Report or Announcement
Regulatory Filings Classification · 1% confidence The document is very short (1545 characters) and explicitly states it is an 'Other Report or Announcement' filed under Israeli regulations. Crucially, it mentions an attached report: 'Attached hereto is a report on *S-8* *Form_S-8_isa.pdf*'. The S-8 form is typically a registration statement related to employee stock option plans, which is a specific regulatory filing. Since this document is merely announcing the attachment of the S-8 form rather than containing the full content of the S-8 itself, it fits the 'Menu vs Meal' rule. Given that it is a specific regulatory filing announcement that doesn't fit the other specific categories (like DIV, ER, 10-K), the most appropriate classification is the general Regulatory Filings category (RNS), as it is a miscellaneous regulatory announcement.
2015-11-10 English
Immediate Report
Regulatory Filings
2015-10-18 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.